Valuation: Consun Pharmaceutical Group Limited

Market Cap 11.28B 13.24B 1.69B 1.51B 1.38B 1.26B 2.38B 159B 2.46B 16.68B 6.65B 84.7B 6.34B 6.2B 267B P/E 2026 *
9.27x
P/E 2027 * 8.42x
Enterprise Value 11.28B 13.24B 1.69B 1.51B 1.38B 1.26B 2.38B 159B 2.46B 16.68B 6.65B 84.7B 6.34B 6.2B 267B EV / Sales 2026 *
2.9x
EV / Sales 2027 * 2.59x
Free-Float
54.17%
Yield 2026 *
5.39%
Yield 2027 * 5.95%
1 week+3.48%
Current month+3.48%
1 month+6.26%
3 months+12.71%
6 months+4.71%
Current year+0.90%
1 week 15
Extreme 15
15.98
1 month 14.52
Extreme 14.52
16.18
Current year 12.31
Extreme 12.31
19.49
1 year 12.31
Extreme 12.31
19.49
3 years 4.38
Extreme 4.38
19.49
5 years 2.92
Extreme 2.92
19.49
10 years 2.61
Extreme 2.61
19.49
Manager TitleAgeSince
Chief Executive Officer 54 2024-01-16
Director of Finance/CFO 46 2025-02-23
Corporate Secretary 58 -
Director TitleAgeSince
Director/Board Member 86 2012-12-23
Director/Board Member 67 2013-12-01
Chairman 54 2021-07-08
Date Insider Type Main position Quantity % Market Cap. Importance
7/17/25 Other

Chief Executive Officer

50,000 0.0059%
7/17/25 Other

Chief Executive Officer

50,000 0.0059%
7/15/25 Other

Chief Executive Officer

136,000 0.0160%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+3.48%+5.98%+229.44% 1.69B
-0.79%-4.48%+46.48%+125.69% 1,206B
+1.43%+1.11%+48.05%+83.05% 665B
+1.07%-1.21%+32.92%+104.92% 515B
-0.36%-3.25%+45.42%+65.10% 381B
-0.14%-1.87%+70.06%+41.09% 362B
-0.78%-0.52%+30.47%+58.09% 307B
-0.80%-0.21%+7.98%+36.17% 289B
+0.03%-1.20%+43.79%+69.83% 249B
-0.41%-2.22%+40.43%+107.03% 207B
Average -0.08%-1.04%+37.16%+92.04% 418.14B
Weighted average by Cap. -0.04%-1.95%+42.69%+88.17%

Financials

2026 *2027 *
Net sales 3.88B 4.56B 581M 521M 477M 435M 820M 54.65B 845M 5.74B 2.29B 29.16B 2.18B 2.14B 92.05B 4.35B 5.11B 651M 584M 534M 487M 918M 61.24B 947M 6.44B 2.57B 32.68B 2.45B 2.39B 103B
Net income 1.24B 1.45B 185M 166M 152M 138M 261M 17.39B 269M 1.83B 729M 9.28B 694M 680M 29.3B 1.36B 1.6B 204M 183M 167M 153M 288M 19.18B 297M 2.02B 804M 10.23B 766M 749M 32.31B
Net Debt - -
Projected Income Statement - Annual - Consun Pharmaceutical Group Limited
Logo Consun Pharmaceutical Group Limited
Consun Pharmaceutical Group Ltd is a company principally engaged in manufacturing and sales of pharmaceutical products. The Company operates its businesses through two segments. Consun Pharmaceutical segment is mainly engaged in manufacturing and sells of modern Chinese medicines and medical contrast medium. Yulin Pharmaceutical segment is mainly involved in manufacturing and sells of traditional Chinese medicines. The Company's products include kidney medicines, gynaecology and paediatrics medicines, contrast medium, orthopedics medicines, dermatologic medicines, hepatobiliary medicines and others. The Company mainly operates its businesses in the domestic market.
Employees
2,847
Date Price Change Volume
26-11-06 HK$15.78 0.00% 1,360,118
26-11-05 HK$15.78 +0.77% 1,075,000
26-11-04 HK$15.66 +1.69% 1,068,097
26-11-03 HK$15.40 +0.52% 993,000
26-11-02 HK$15.32 +0.46% 1,025,000
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - Consun Pharmaceutical Group Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
13.44CNY
Average target price
19.36CNY
Spread / Average Target
+44.00%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Consun Pharmaceutical Group Limited
  1. Stock Market
  2. Stocks
  3. 1681 Stock